These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32093271)

  • 21. Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia.
    Noto D; Cefalù AB; Cannizzaro A; Minà M; Fayer F; Valenti V; Barbagallo CM; Tuttolomondo A; Pinto A; Sciumè C; Licata G; Averna M
    Atherosclerosis; 2009 Sep; 206(1):193-8. PubMed ID: 19344897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
    Di Leo E; Eminoglu T; Magnolo L; Bolkent MG; Tümer L; Okur I; Tarugi P
    J Clin Lipidol; 2015; 9(3):400-5. PubMed ID: 26073401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
    Heeks LV; Hooper AJ; Adams LA; Robbins P; Barrett PH; van Bockxmeer FM; Burnett JR
    Clin Chim Acta; 2013 Jun; 421():121-5. PubMed ID: 23694813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a Variant in
    Ayoub C; Azar Y; Abou-Khalil Y; Ghaleb Y; Elbitar S; Halaby G; Jambart S; Gannagé-Yared MH; Yaghi C; Saade Riachy C; El Khoury R; Rabès JP; Varret M; Boileau C; El Khoury P; Abifadel M
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial hypobetalipoproteinemia: clinical characterization of a new mutation in the APOB gene].
    Iglesias P; Díez JJ; Tarugi P
    Med Clin (Barc); 2009 Jun; 133(2):57-60. PubMed ID: 19442995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: A case report and review.
    Rodríguez de Vera-Gómez P; Del Pino-Bellido P; García-González JJ; Sánchez-Jiménez F; Oliva-Rodríguez R; Arrobas-Velilla T; Martínez-Brocca MA
    J Clin Lipidol; 2022; 16(5):601-607. PubMed ID: 35918255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia.
    Burnett JR; Shan J; Miskie BA; Whitfield AJ; Yuan J; Tran K; McKnight CJ; Hegele RA; Yao Z
    J Biol Chem; 2003 Apr; 278(15):13442-52. PubMed ID: 12551903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
    Elias N; Patterson BW; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.
    Najah M; Di Leo E; Awatef J; Magnolo L; Imene J; Pinotti E; Bahri M; Barsaoui S; Brini I; Fekih M; Slimane MN; Tarugi P
    Clin Chim Acta; 2009 Mar; 401(1-2):51-6. PubMed ID: 19056372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hypobetalipoproteinemia: genetics and metabolism.
    Schonfeld G; Lin X; Yue P
    Cell Mol Life Sci; 2005 Jun; 62(12):1372-8. PubMed ID: 15818469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
    Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
    Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B.
    Bonnefont-Rousselot D; Condat B; Sassolas A; Chebel S; Bittar R; Federspiel MC; Cazals-Hatem D; Bruckert E
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):104-8. PubMed ID: 19060634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel APOB mutation in familial hypobetalipoproteinemia.
    Domenech M; Llano-Rivas I; Arroyo V; Ortega E
    J Clin Lipidol; 2022; 16(1):28-32. PubMed ID: 34852964
    [No Abstract]   [Full Text] [Related]  

  • 35. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
    Burnett JR; Zhong S; Jiang ZG; Hooper AJ; Fisher EA; McLeod RS; Zhao Y; Barrett PH; Hegele RA; van Bockxmeer FM; Zhang H; Vance DE; McKnight CJ; Yao Z
    J Biol Chem; 2007 Aug; 282(33):24270-83. PubMed ID: 17588943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene.
    Tarugi P; Lonardo A; Gabelli C; Sala F; Ballarini G; Cortella I; Previato L; Bertolini S; Cordera R; Calandra S
    J Lipid Res; 2001 Oct; 42(10):1552-61. PubMed ID: 11590210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor splice mutation (665 + 1 G_T) in familial hypobetalipoproteinemia with no detectable apoB truncation.
    Pulai JI; Zakeri H; Kwok PY; Kim JH; Wu J; Schonfeld G
    Am J Med Genet; 1998 Nov; 80(3):218-20. PubMed ID: 9843041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL.
    Yue P; Isley WL; Harris WS; Rosipal S; Akin CD; Schonfeld G
    Atherosclerosis; 2005 Jan; 178(1):107-13. PubMed ID: 15585207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
    Hooper AJ; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PHR; van Bockxmeer FM; Burnett JR
    Clin Biochem; 2016 Jun; 49(9):720-722. PubMed ID: 26916057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.